SCHEMBL16822709

SCHEMBL16822709

C=C(C)C(=O)OCC(C)(C)COCc1cc(-c2ccc(S(=O)(=O)c3ccc(-c4ccc(OC)c(COCC(C)(C)COC(=O)C(=C)C)c4)cc3)cc2)ccc1OC

nearest known ligand 0.37

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.37
ALDH1A1 P00352 4/20 0.37
MMP2 P08253 4/20 0.33
MMP9 P14780 4/20 0.33
MMP12 P39900 4/20 0.33
MMP1 P03956 2/20 0.33
MMP3 P08254 2/20 0.33
MMP8 P22894 2/20 0.33
MMP13 P45452 2/20 0.33
MMP14 P50281 2/20 0.33
MMP16 P51512 2/20 0.33
POLB P06746 1/20 0.33
TSHR P16473 1/20 0.33
MAPK1 P28482 1/20 0.33
PKM P14618 1/20 0.33
ALOX5 P09917 1/20 0.31
MEN1 O00255 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16843134 0.96 ALDH1A1 (0.35) KMT2AALDH1A1MMP2MMP9MMP12
SCHEMBL19564843 0.95 ALDH1A1 (0.34) KMT2AALDH1A1MMP2MMP9MMP12
SCHEMBL18044123 0.93 ALOX5 (0.35) KMT2AALDH1A1POLBTSHRMAPK1
SCHEMBL16840304 0.92 ALDH1A1 (0.33) KMT2AALDH1A1MMP2MMP9MMP12
SCHEMBL19569884 0.89 THRB (0.34) KMT2AALDH1A1MMP2MMP9MMP12
SCHEMBL16840308 0.88 ALDH1A1 (0.30) KMT2AALDH1A1
SCHEMBL24117423 0.88 KMT2A (0.40) KMT2AALDH1A1POLBTSHRMAPK1
SCHEMBL21889385 0.88 KMT2A (0.36) KMT2AALDH1A1POLBTSHRMAPK1
SCHEMBL16843087 0.88 PLA2G2A (0.31) KMT2AALDH1A1
SCHEMBL20924636 0.87 POLB (0.34) KMT2AALDH1A1MMP2MMP9MMP12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10370474-B2 Optical composition, cured product, and optical element CANON KABUSHIKI KAISHA (JP) 2019-08-06 US disclosed
US-20170320984-A1 OPTICAL COMPOSITION, CURED PRODUCT, AND OPTICAL ELEMENT CANON KABUSHIKI KAISHA (JP) 2017-11-09 US disclosed
US-9290597-B2 (Meth)acrylate compound, optical composition, molded article, and optical element CANON KABUSHIKI KAISHA (JP) 2016-03-22 US disclosed
US-20150175731-A1 (METH)ACRYLATE COMPOUND, OPTICAL COMPOSITION, MOLDED ARTICLE, AND OPTICAL ELEMENT CANON KABUSHIKI KAISHA (JP) 2015-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150175731-A1 (METH)ACRYLATE COMPOUND, OPTICAL COMPOSITION, MOLDED ARTICLE, AND OPTICAL ELEMENT SMYD2, ZYX, MMAB KMT2A 280/4885ALDH1A1 921/4885MMP2 4635/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.